Chemoinformaics analysis of 6,6,8,9-TETRAMETHYL-2-OXATETRACYCLO[6.4.0.01,3.05,7]DODECANE
| Molecular Weight | 220.356 | nRot | 0 |
| Heavy Atom Molecular Weight | 196.164 | nRig | 3 |
| Exact Molecular Weight | 220.183 | nRing | 4 |
| Solubility: LogS | -4.412 | nHRing | 1 |
| Solubility: LogP | 4.59 | No. of Aliphatic Rings | 4 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 16 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 3 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 4 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 41.855 |
| nHD | 0 | BPOL | 25.813 |
| QED | 0.297 |
| Synth | 4.334 |
| Natural Product Likeliness | 2.513 |
| NR-PPAR-gamma | 0.711 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.04 |
| CACO-2 | -4.03 |
| MDCK | 0.0000272 |
| BBB | 0.032 |
| PPB | 1.00872 |
| VDSS | 1.63 |
| FU | 0.0120294 |
| CYP1A2-inh | 0.491 |
| CYP1A2-sub | 0.734 |
| CYP2c19-inh | 0.91 |
| CYP2c19-sub | 0.752 |
| CYP2c9-inh | 0.875 |
| CYP2c9-sub | 0.983 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.511 |
| CYP3a4-inh | 0.84 |
| CYP3a4-sub | 0.133 |
| CL | 6.676 |
| T12 | 0.16 |
| hERG | 0.001 |
| Ames | 0.395 |
| ROA | 0.941 |
| SkinSen | 0.857 |
| Carcinogencity | 0.508 |
| EI | 0.718 |
| Respiratory | 0.963 |
| NR-Aromatase | 0.889 |
| Antiviral | Yes |
| Prediction | 0.830479 |